Clinical Trial

Vaccine Immunity and Inflammation in the Aging Person Living With HIV

Study acronym: VIVID
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-16; most recent amendment 2025-06-09.
Trial Details
NCT Number NCT06514547
Lead Sponsor Hennepin Healthcare Research Institute
Collaborators: National Institute on Aging (NIA)
Conditions HIV Infections, Age
Enrollment 250 participants
Start Date 2024-07-08
Primary Completion 2028-09-15 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-12